Biochemistry: Hagman and Grosschedl

   

vinyb/v-ets ~- S A S A
ETS binding — wt wt mut mut
site
Fic. 5, The MUF?2 site in the mb-1 Promoter mediates trans-
activation by v-myb—v-ets protein. Three tandem copies of the mut
oligonucleotide (see Fig. 14), which contains a wt MUF? site and a
mutated Sp1-binding site, were inserted immediately upstream of the
c-fos minimal promoter linked to the CAT reporter gene (3). As a
control, the mut3 oligonucleotide, which contains mutations in both
sites (see Fig. 1A), was used to construct a mutant reporter plasmid.
wt and mutant (mut) reporter plasmids were transfected together
with an effector plasmid encoding a v-myb-v-cts fusion protein (178
carboxyl-terminal amino acids of v-niyb fused to the entire 491 amino
acids of v-ets) expressed in the Sense (S) or antisense (A) orientation
from the cytomegalovirus enhancer/promoter. A Rous sarcoma
Virus—tuciferase plasmid was included as a control for transfection
efficiency. Cell lysates were Prepared 42 hr after transfection, lysates
for CAT assays were hormalized for luciferase activity, and CAT
activity was quantitated by using the PhosphorImager.

enhancer region is altered by the addition of myeloma nuclear
extract (30). (Gif) The mammalian transcription factor GABP
is composed of the ETS-related GABPa and notch-related
GABP8 subunits (31). Using the mb-/ proximal promoter
region (-59 to —38) as a probe, we have not observed any
changes in the mobility of protein-DNA complexes after
adding early B-cell nuclear extracts to binding reactions
containing the ETS family factors described in this study
(data not shown). However,.the interaction of the ETS
factors with nuclear proteins may: not be readily detectable
because of their low abundance;

The carboxyl terminus of Ets-1 could inhibit DNA binding
by a number of different mechanisms, The carboxyl terminus
could interact directly with amino acids that contact DNA. In
a variation of this model, the carboxyl terminus could interact
with another region of the polypeptide. Indeed, a second
internal inhibitory domain was recently identified in Ets-1,
Suggesting that binding is inhibited by specific intramolecular
Contacts between both domains (32). This result is consistent
with our observation that a peptide containing the carboxyl-
terminal 15 amino acids of Ets-1 did not inhibit DNA binding
when incubated with Ets-1AC (lacking these’ same amino
acids) at peptide concentrations up to 1 mM (data not shown).
Moreover, the carboxyl termirius ‘Of Ets-1 had only a minor
effect on the DNA binding of PU-1/Ets-1 chimeric polypep-
tides, although PU.1 and Ets-1 récognize similar DNA se-
quences. . Bee moh .

Of the ETS family factors tested $0 far, only the v-myb-
v-ets fusion protein. was able to appreciably transactivate
transcription through the MUF site. We suspect that the
relatively high binding affinity of v-ets for this site, together
with the presence of two putative activation domains (one in
the carboxyl-terminal domain of. v-myb and one in the
amino-terminal domain of y-ets; refs. 23 and 32), accounts for
this effect. As previously suggested, the inability of the
cellular ETS proteins to activate transcription in similar
assays may reflect the need for interactions with other
transcription factors bound to the promoter. Studies of ETS

  

Proc. Natl. Acad, Sci. USA 89 (1992) 8893

family Proteins and other factors bound to the mb-1 promoter
may explain how a specific member of a family of nuclear

peters is recruited for the activation of transcription in early
B cells.

of America. This study was supported by funds from the Howard
Hughes Medical Institute.

lL. Cambier, J. C. (1991) Curr, Opin. Immunol. 1, 25-27,

2. Sakaguchi, N., Kashiwamura, S.-i., Kimoto, M., Thalmann, P.
& Melchers, F. (1988) EMBO J. 7, 3457-3464,

3. Travis, A., Hagman, J. & Grosschedl, R. (1991) Mol. Cell, Bial.
11, 5756~5766.

4, Wasylyk, B., Wasylyk, C., Flores, P., Begue, A., Leprince, D.
& Stehelin, D. (1990) Nature (London) 346, 191-193.

5. Leiden, J. M. (1992) Immunol, Today 13, 22-30.

6. Karim, F. D., Umess, L. D., Thummel, C. S., Kiemsz, M. dL,
McKercher, S. R., Celada, A., Van Beveren, C., Maki, R. A.,
Gunther, C. V., Nye, J. A. & Graves, B. J. (1990) Genes Dev.
4, 1451-1453.

7. Ghysdael, J., Gegonne, A., Pognonec, P., Demis, D., Lep-

tince, D. & Stehelin, D. (1986) Proc. Natl. Acad. Sci. USA 83,
1714-1718.

8. Bhat, N. K., Fisher, R. J., Fujiwara, S., Ascione, R. & Papas,
T. S. (1987) Proc. Natl. Acad. Sci. USA 84, 3161-3165,

9. Watson, D. K., McWilliams, M. J., Lapis, P., Lautenberger,
J. A., Schweinfest, C. W, & Papas, T. S. (1988) Proc. Nail.
Acad. Sci, USA 85, 7862-7866.

10. Leprince, D., Gesquiere, J.C. & Stehelin, D. (1990) Oncogene
Res. §, 255-265,

ll. Klemsz, M. J., McKercher, S. R., Celada, A., Van Beveren,
C. & Maki, R. A, (1990) Cell 61, 113-124.

12. Boutukos, K. E., Pognonec, P., Begue, A., Galibert, F., Ges-
quiere, J. C., Stehelin, D. & Ghysdael, J. (1988) EMBO J. 7,
697-705,

13. Nunn, M. F., Seeburg, P. H., Moscovici, C. & Duesburg,
P.H. (1983) Nature (London) 306, 391-395,

14. Leprince, D., Gegonne, A., Coll, J., de Taisne, C., Schnee-
burger, A., Lagrou, C. & Stehelin, D. (1983) Nature (London)
306, 395-397,

15. Travis, A., Amsterdam, A., Belanger, C. & Grosschedi, R.
(1991) Genes Dev, §, 880-894.

16. Chen, J. H. (1990) Oncogene Res. §, 277-285.

17. Matthias, P., Muller, M. M., Schreiber, E., Rusconi, §. &
Schaffner, W. (1989) Nucleic Acids Res. 17, 6418.

18. Grosschedl, R. & Baltimore, D. (1985) Cet 41, 885-897.

19. Ho, J.-C., Bhat, N. K., Gottschalk, L. R., Lindstein, T.,
Thompson, C. B., Papas, T. S. & Leiden, J. M. (1990) Science
250, 814=818.

20. Martin, M. E., Piette, J., Yaniv, M., Tang, W. J. & Folk,
W. R. (1988) Proc. Natl. Acad. Sci. USA 88, 5839-5843,

21. Gunther, C. V., Nye, J. A., Bryner, R. S. & Graves, B. J.
(1990) Genes Dev, ‘4, 667-679.

22, Klempnauer, K.-H. & Sippel, A. E. (1987) EMBO J. 6, 2719-
2725.

23. Weston, K. & Bishop, J. M. (1989) Cell 58, 85-93.

24. Hagman, J., Travis, A. & Grosschedl, R. (1991) EMBO J. 10,
3409-3417. ‘

25. Pognonee, P.,-Boulukos, K. E., Gesquiere, J. C., Stehelin, D.
& Ghysdael, 3.1988). EMBO J. 7, 977-983.

26. Koizumi, $.,.Fisher, R. J., Fujiwara, S., Jorcyk, C., Bhat,

” NLK,, Seth, & Papas, T. (1990) Oncogene 5, 675-681.

27. Fisher, C..L., Gi vysdael, J. & Cambier, J. (1991) J. Immunol.
146, 1743-1749,

28. Hipskind, R. A:,. Rao, V.N., Mueller, C. G. F., Reddy,
E. S.P.& Nordheim, A. (1991) Nature (London) 384, 531-534.

29. Dalton, S.& Treisman, R. (1992) Cell 68, 597-612.

30, Pongubala, J. M. R., Nagulapalli, S., Klemsz, M. J., McKercher,
S.R., Maki, R. A. & Acthison, M. L, (1992) Mol. Cell Biol. 12,
368-378.

31, LaMarco, K., Thompson, C. C., Byers, B. P., Walton, E. M.
& McKnight, S. L. (1991) Science 253, 789-791,

32, Lim, F., Kraut, N., Frampton, J. & Graf, T. (1992) EMBO J.
11, 643-652.